Literature DB >> 17409209

Agreement between self- and clinician-collected specimen results for detection and typing of high-risk human papillomavirus in specimens from women in Gugulethu, South Africa.

Heidi E Jones1, Bruce R Allan, Janneke H H M van de Wijgert, Lydia Altini, Sylvia M Taylor, Alana de Kock, Nicol Coetzee, Anna-Lise Williamson.   

Abstract

We assessed the agreement in detection of high-risk human papillomavirus (HPV), as well as specific HPV types, between self- and clinician-obtained specimens for 450 women over 18 years of age attending a community health center in Gugulethu, South Africa. Both self-collected swabs and tampons had high agreement with clinician-obtained brushes when the Roche Reverse Line Blot Assay (RLBA) was used (for swabs, 86% concordance, with a kappa statistic [kappa] of 0.71; for tampons, 89% concordance, with kappa of 0.75). Agreement was lower, although still fair, with the Digene Hybrid Capture 2 test (HC2), with kappa higher for swabs than for tampons (for swabs, 81% concordance, with kappa of 0.61; for tampons, 82% concordance, with kappa of 0.55). Low-risk HPV types were nearly two times more common in self-collected specimens than in clinician-collected specimens tested by RLBA. All 15 women diagnosed with high-grade lesions by cytology tested positive for high-risk HPV with clinician-collected specimens tested by RLBA and HC2, while 11 out of 15 tested positive with self-collected specimens by HC2 and 5 out of 6 tested positive by RLBA. Self-collected specimens can provide valid specimens for HPV testing using nucleic acid amplification tests, although a few cytological abnormalities may be missed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17409209      PMCID: PMC1933028          DOI: 10.1128/JCM.02369-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Randomized clinical trial of PCR-determined human papillomavirus detection methods: self-sampling versus clinician-directed--biologic concordance and women's preferences.

Authors:  Diane M Harper; Walter W Noll; Dorothy R Belloni; Bernard F Cole
Journal:  Am J Obstet Gynecol       Date:  2002-03       Impact factor: 8.661

2.  HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer.

Authors:  T C Wright; L Denny; L Kuhn; A Pollack; A Lorincz
Journal:  JAMA       Date:  2000-01-05       Impact factor: 56.272

3.  Human papillomavirus vaccines: what does the future hold for preventing cervical cancer in resource-poor settings through immunization programs?

Authors:  Martha Jacob; Janet Bradley; Mark A Barone
Journal:  Sex Transm Dis       Date:  2005-10       Impact factor: 2.830

4.  Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women.

Authors:  M A E Nobbenhuis; T J M Helmerhorst; A J C van den Brule; L Rozendaal; L H Jaspars; F J Voorhorst; R H M Verheijen; C J L M Meijer
Journal:  J Clin Pathol       Date:  2002-06       Impact factor: 3.411

5.  The acceptability of self-collected samples for HPV testing vs. the pap test as alternatives in cervical cancer screening.

Authors:  Ilana G Dzuba; Elsa Yunes Díaz; Betania Allen; Yvonne Flores Leonard; Eduardo C Lazcano Ponce; Keerti V Shah; David Bishai; Attila Lorincz; Daron Ferris; Bernardo Turnbull; Mauricio Hernández Avila; Jorge Salmerón
Journal:  J Womens Health Gend Based Med       Date:  2002-04

6.  Tampon samplings with longer cervicovaginal cell exposures are equivalent to two consecutive swabs for the detection of high-risk human papillomavirus.

Authors:  Diane M Harper; Meghan Raymond; Walter W Noll; Dorothy R Belloni; Laura Therrien Duncan; Bernard F Cole
Journal:  Sex Transm Dis       Date:  2002-11       Impact factor: 2.830

7.  Acceptability of human papillomavirus self testing in female adolescents.

Authors:  J A Kahn; D I Bernstein; S L Rosenthal; B Huang; L M Kollar; J L Colyer; A M Tissot; P A Hillard; D Witte; P Groen; G B Slap
Journal:  Sex Transm Infect       Date:  2005-10       Impact factor: 3.519

8.  Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction.

Authors:  P E Gravitt; J V Lacey; L A Brinton; W A Barnes; J R Kornegay; M D Greenberg; S M Greene; O C Hadjimichael; L McGowan; R Mortel; P E Schwartz; R Zaino; A Hildesheim
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-02       Impact factor: 4.254

9.  Human papillomavirus detection for cervical cancer prevention with polymerase chain reaction in self-collected samples.

Authors:  Felipe R Lorenzato; Albert Singer; Linda Ho; Luiz Carlos Santos; Raimundo de Lucena Batista; Telma M Lubambo; George Terry
Journal:  Am J Obstet Gynecol       Date:  2002-05       Impact factor: 8.661

10.  Self-sampling is associated with increased detection of human papillomavirus DNA in the genital tract of HIV-seropositive women.

Authors:  Patrick Petignat; Catherine Hankins; Sharon Walmsley; Deborah Money; Diane Provencher; Karina Pourreaux; Janet Kornegay; Fabrice Rouah; François Coutlée
Journal:  Clin Infect Dis       Date:  2005-07-14       Impact factor: 9.079

View more
  18 in total

1.  Suitability of self-collected vaginal samples for cervical cancer screening in periurban villages in Andhra Pradesh, India.

Authors:  A Pavani Sowjanya; Proma Paul; Haripriya Vedantham; Gayatri Ramakrishna; D Vidyadhari; K Vijayaraghavan; Shantha Laksmi; Mrudula Sudula; Brigitte M Ronnett; Manik Das; Keerti V Shah; Patti E Gravitt
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05       Impact factor: 4.254

Review 2.  The burden of human papillomavirus infections and related diseases in sub-saharan Africa.

Authors:  Hugo De Vuyst; Laia Alemany; Charles Lacey; Carla J Chibwesha; Vikrant Sahasrabuddhe; Cecily Banura; Lynette Denny; Groesbeck P Parham
Journal:  Vaccine       Date:  2013-12-29       Impact factor: 3.641

Review 3.  Looking ahead: a case for human papillomavirus testing of self-sampled vaginal specimens as a cervical cancer screening strategy.

Authors:  Patti E Gravitt; Jerome L Belinson; Jorge Salmeron; Keerti V Shah
Journal:  Int J Cancer       Date:  2011-08-01       Impact factor: 7.396

4.  Comparison of sampling methods to measure HIV RNA viral load in female genital tract secretions.

Authors:  Shameem Z Jaumdally; Heidi E Jones; Donald R Hoover; Hoyam Gamieldien; Jean-Mari Kriek; Nontokozo Langwenya; Landon Myer; Jo-Ann S Passmore; Catherine S Todd
Journal:  Am J Reprod Immunol       Date:  2017-01-23       Impact factor: 3.886

5.  A Viable and Simple Self-Sampling Method for Human Papillomavirus Detection among South African Adolescents.

Authors:  David H Adler; Fatima Laher; Erica Lazarus; Katherine Grzesik; Glenda E Gray; Bruce Allan; Anna-Lise Williamson
Journal:  J Immunol Tech Infect Dis       Date:  2013-09-18

6.  High level of agreement between clinician-collected and self-collected samples for HPV detection among South African adolescents.

Authors:  D H Adler; A Almudevar; G E Gray; B Allan; A-L Williamson
Journal:  J Pediatr Adolesc Gynecol       Date:  2012-08       Impact factor: 1.814

7.  A comparison of cervical and vaginal human papillomavirus.

Authors:  Philip E Castle; Ana C Rodriguez; Carolina Porras; Rolando Herrero; Mark Schiffman; Paula Gonzalez; Allan Hildesheim; Robert D Burk
Journal:  Sex Transm Dis       Date:  2007-11       Impact factor: 2.830

8.  A qualitative analysis of factors influencing HPV vaccine uptake in Soweto, South Africa among adolescents and their caregivers.

Authors:  Ingrid T Katz; Busisiwe Nkala; Janan Dietrich; Melissa Wallace; Linda-Gail Bekker; Kathryn Pollenz; Laura M Bogart; Alexi A Wright; Alexander C Tsai; David R Bangsberg; Glenda E Gray
Journal:  PLoS One       Date:  2013-08-30       Impact factor: 3.240

9.  Acceptability and Accuracy of Cervical Cancer Screening Using a Self-Collected Tampon for HPV Messenger-RNA Testing among HIV-Infected Women in South Africa.

Authors:  Paul C Adamson; Megan J Huchko; Alison M Moss; Hans F Kinkel; Andrew Medina-Marino
Journal:  PLoS One       Date:  2015-09-02       Impact factor: 3.240

10.  Human papillomavirus prevalence in South African women and men according to age and human immunodeficiency virus status.

Authors:  Zizipho Z A Mbulawa; David Coetzee; Anna-Lise Williamson
Journal:  BMC Infect Dis       Date:  2015-10-26       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.